Polymyalgia rheumatica and shoulder stiffness: why assessment comes before PRP

An adult woman seated indoors with a hand resting on her shoulder

Shoulder discomfort has several possible causes. Illustrative photograph, not a PMR diagnosis, a clinic client or a treatment result.

Pain and morning stiffness across both shoulders, sometimes with hip or neck discomfort, can need a different assessment from an isolated tendon injury. Polymyalgia rheumatica, often called PMR, is one possible explanation in adults over 50. PRP is not an established treatment for PMR. The first priority is to identify the cause and recognise symptoms that need urgent medical attention.

What is polymyalgia rheumatica?

PMR is an inflammatory condition that commonly causes aching and stiffness around the shoulders and hips. The symptoms can make ordinary movements uncomfortable, including dressing, turning in bed or getting out of a chair. Neck discomfort may be part of the same picture. The condition affects the tissues around these joints rather than behaving like a single torn tendon that can be identified from one painful movement.

It occurs almost exclusively after the age of 50 and is more common in older adults. Age alone does not establish the diagnosis. Many people in this age group also have osteoarthritis, tendon changes or other causes of shoulder discomfort. A careful assessment brings together the pattern of symptoms, examination, blood results and the possibility of another condition.

Which pattern of stiffness matters?

Morning stiffness lasting longer than about 45 minutes is a recognised feature of PMR. Symptoms often affect both sides and may be particularly intrusive after rest. Fatigue, reduced appetite or unintentional weight loss can occur alongside the pain. These features are useful clinical clues, not a checklist that confirms PMR without a consultation.

A sore shoulder after a new activity can have a different explanation. Pain that is closely related to a particular movement may point towards a local problem, although inflammatory and mechanical conditions can overlap. The distinction matters because treatment should address the cause, not simply the area that happens to hurt most that day.

New symptoms affecting daily activities deserve medical review. Waiting for an injection appointment is not the right way to investigate unexplained bilateral stiffness, especially when there are wider symptoms or a recent change in general health.

When do headache or visual symptoms need urgent help?

Some people with PMR also develop giant cell arteritis, sometimes called temporal arteritis. This is inflammation of arteries that can threaten sight and cause other serious complications. A new headache, scalp or temple tenderness, jaw pain when chewing or talking, or a change in vision needs urgent medical advice. These symptoms should not be attributed to shoulder tension without assessment.

If giant cell arteritis is suspected, seek an urgent GP appointment or contact NHS 111. Problems with vision require same-day specialist assessment, usually through a hospital eye service. Do not wait for a routine PRP enquiry, a blood-test appointment or a reply to a non-urgent message. Treatment may need to begin before all the diagnostic tests are complete.

A previous PMR diagnosis does not make new visual symptoms expected or harmless. These warning symptoms also matter in someone who has not yet been diagnosed with PMR. Tell the clinician about the shoulder and hip symptoms as well as the headache or visual change, so the whole pattern can be considered together.

Why can PMR resemble a shoulder injury?

Both PMR and local shoulder disorders can cause difficulty lifting the arms, dressing or sleeping comfortably. Pain may make the arm feel weak even when the main problem is stiffness. Other conditions, including inflammatory arthritis and muscle disease, can produce similar difficulties. Describing an arm as weak does not on its own reveal which tissue or process is responsible.

The examination therefore looks beyond one painful spot. A clinician may assess movement at both shoulders, the hips and neck, as well as strength and other relevant findings. True progressive loss of strength, visible muscle wasting or neurological symptoms may require a different investigation pathway. It is possible to have more than one diagnosis, but that should be demonstrated rather than assumed.

An older scan showing tendon wear does not automatically explain a new pattern of widespread morning stiffness. Imaging findings need to match the current history and examination. An injection directed at an incidental scan finding could leave the actual cause of symptoms untreated.

Can blood tests confirm the diagnosis?

There is no single blood test that proves PMR. ESR and CRP are commonly used to look for inflammation, but raised results can occur with many other conditions. A result becomes meaningful when interpreted alongside symptoms, examination and the wider clinical picture. A high inflammatory marker is not a reason to proceed directly to a particular treatment.

Normal inflammatory markers make the usual PMR presentation less likely, but a clinician still needs to decide whether another diagnosis or further assessment is required. Individual results should not be used in isolation to dismiss continuing symptoms. Other tests may be appropriate to investigate alternative causes or establish a baseline before treatment, depending on the history.

Previous results can be useful because they show whether a change is new. The aim is not to order the largest possible panel. It is to answer a specific clinical question and agree what happens after the results are available. Blood tests must not delay urgent assessment when symptoms suggest giant cell arteritis.

What role do scans and specialist assessment have?

Ultrasound can sometimes support the assessment by showing inflammation around the shoulders or hips. It does not replace the clinical history, and no single scan finding confirms every case of PMR. X-rays or other imaging may be considered when the clinician needs to investigate another explanation. The appropriate test depends on the question being asked.

Specialist rheumatology advice may be needed when the presentation is unusual, the diagnosis remains uncertain, symptoms respond poorly to treatment or the treatment course becomes difficult. Atypical symptoms deserve attention rather than repeated treatment for an assumed local injury. Suspected giant cell arteritis follows an urgent pathway rather than an ordinary musculoskeletal referral.

A recent clinical review of PMR describes continuing diagnostic uncertainty and the importance of recognising conditions that mimic it. That is a reason for a considered assessment, not a reason to promise that one scan or consultation can settle every case. The plan should explain which findings support the working diagnosis and which changes would prompt reassessment.

How is PMR usually treated?

Prescribed corticosteroid treatment remains central to usual PMR care. The dose and subsequent reductions are individual decisions made by the treating clinician. The purpose is to control symptoms and inflammation while limiting treatment-related harm. This article does not provide a dosing schedule, and improvement after taking steroids is not a safe self-test for PMR.

Treatment can continue for a prolonged period and symptoms may return during dose reduction or after treatment ends. Follow-up reviews assess symptoms, function, blood results where appropriate and possible side effects. Some people need specialist treatment to reduce repeated steroid exposure. The choice depends on the diagnosis, previous response, other health conditions and current guidance.

A local injection and a course of prescribed treatment for a systemic inflammatory condition are not interchangeable. Feeling that a particular shoulder is most painful does not mean the underlying condition can be managed by injecting that shoulder. The treatment plan needs to fit the whole illness.

Why should prescribed medicine not be stopped for a PRP enquiry?

Do not stop prescribed steroids or change their dose because you are considering PRP. Sudden withdrawal can make you seriously unwell. If symptoms return during a planned reduction, contact the clinician managing the PMR rather than making an independent change or replacing treatment with an injection enquiry. The same care applies to other prescribed medicines.

Tell any clinician assessing a separate joint or tendon problem about your PMR, current medicines and recent changes. Steroids, immune-suppressing treatment, medicines affecting bleeding and other health conditions can all be relevant to procedure planning. The treating teams should decide whether a proposed procedure is appropriate and how it fits with your existing care.

Preparation instructions published by another hospital describe that hospital's procedure and are not permission to stop your own medicine. An individual written plan is more useful than applying general internet instructions to a different diagnosis or service. Assessment should come before preparation for any intervention.

Does exercise still have a role?

Maintaining activity and function can be part of PMR care, with advice adapted to symptoms, strength, balance and other health conditions. The aim is a manageable level of movement rather than forcing through a flare. A clinician or physiotherapist can help distinguish expected discomfort from a change that needs further assessment and can adjust activity as symptoms improve.

Long periods of reduced activity can make everyday tasks harder. At the same time, a new exercise programme should not be used as a substitute for investigating unexplained pain and stiffness. Exercise advice is most useful when the diagnosis and treatment plan are clear. Progress can be measured in ordinary activities such as dressing, walking or rising comfortably from a chair.

People taking longer courses of steroids also need appropriate monitoring of treatment risks, including bone health. The details belong within the treating clinician's plan. A rehabilitation or wellbeing programme should support that plan, not imply that lifestyle changes alone control the inflammation.

Why is PRP not an established PMR treatment?

Platelet-rich plasma is prepared from a person's blood and injected into a selected area. Its use in a particular tendon or joint condition does not establish it as treatment for PMR. The available PMR sources used for this article describe medical treatment, monitoring and appropriate rehabilitation, not PRP as established disease-control treatment.

Evidence about one diagnosis cannot simply be transferred to another because both involve pain or inflammation. PMR has a systemic inflammatory pattern and a link with giant cell arteritis. A local injection does not replace assessment for either condition and must not delay urgent treatment when the warning symptoms are present.

PRP evidence also differs between individual tendon and joint conditions. NICE guidance on autologous blood injection for tendinopathy describes uncertainty about efficacy and specific governance arrangements. It is not an endorsement of PRP for every painful shoulder, and it does not address PMR as an approved target. A sound discussion is specific about the diagnosis and the limits of the evidence.

Can a separate tendon or joint problem be assessed?

Yes, a person with PMR can also develop an unrelated local musculoskeletal problem. Persistent pain in one clearly defined area may need assessment once the broader illness and any urgent symptoms have been addressed. The question is whether there is a separate diagnosis with a treatment pathway of its own, not whether PRP can replace PMR care.

The assessment should consider the current PMR treatment, infection risk, medicines and the practical goals of care. If PRP is discussed for a separate condition, potential benefit, uncertainty, alternatives and procedure risks need to be explained for that condition. No injection outcome can be guaranteed. A decision not to inject can be the appropriate result of a careful review.

The London PRP Clinic by The Wellness can receive an enquiry about a local joint or tendon concern. This article does not advertise a dedicated PMR service, promise suitability for PRP or replace your rheumatology or GP care. Urgent symptoms belong with urgent medical services, not a routine clinic enquiry.

Discussing a local concern without delaying medical care

For a non-urgent, separately assessed joint or tendon concern, a useful consultation begins with the symptoms, the diagnosis so far and the outcome you want to improve. Existing reports and a current medicine list help keep the discussion connected to your wider care. The value of assessment is deciding what is appropriate, including when another pathway is needed.

Discuss a separate local joint or tendon concern

Frequently asked questions

Does pain in both shoulders mean I have PMR?

No. Bilateral shoulder pain and prolonged morning stiffness can occur with PMR, but other conditions can look similar. Age, symptom pattern, examination and investigations all contribute to the assessment. New persistent symptoms deserve medical review rather than a diagnosis based only on the location of the pain.

Can a normal CRP rule out PMR?

There is no single diagnostic blood test for PMR. Normal inflammatory markers make the usual presentation less likely, but continuing symptoms still need clinical interpretation. A clinician may assess another explanation or decide whether further review is appropriate. Do not use one result to decide independently that treatment or investigation is unnecessary.

Can PRP replace steroid treatment for PMR?

No. PRP is not an established treatment for PMR and should not replace prescribed disease-control treatment. A local tendon or joint procedure addresses a different question. Do not stop steroids or change the dose because you are considering PRP; speak to the clinician responsible for your existing treatment.

What if I develop a new headache or jaw pain?

A new headache, scalp tenderness, jaw pain when chewing or a visual change can suggest giant cell arteritis and needs urgent medical advice. Contact an urgent GP service or NHS 111 rather than waiting for a routine appointment. Visual symptoms need same-day specialist assessment because sight can be threatened.

Can I still have a local shoulder problem as well?

Yes. More than one condition can coexist, but an old scan finding does not prove the cause of new symptoms. A separate local problem should be assessed against the current history, examination and medicines. Any procedure decision needs to fit safely alongside PMR care rather than displace it.

Should I stop my medicines before asking about PRP?

No. An enquiry is not a reason to stop prescribed medicines, including steroids or medicines that affect bleeding. Provide your current medicine list and let the relevant clinicians agree any changes if a procedure is appropriate. Sudden steroid withdrawal can be dangerous and needs particular care.

Sources

NHS, Polymyalgia rheumatica

NHS, Polymyalgia rheumatica diagnosis

NHS, Polymyalgia rheumatica treatment

NHS, Temporal arteritis

Rheumatology and Therapy, Modern Management of Isolated Polymyalgia Rheumatica

Hospital information, PRP blood injection

NICE, Autologous blood injection for tendinopathy recommendations

Next
Next

Myositis and muscle weakness: why assessment comes before PRP